» TAT 2010 meeting, March 4-6, with NCI and ESMO

home / conferences / TAT 2010
 
 
Symposium
   
 


8th INTERNATIONAL SYMPOSIUM ON TARGETED ANTICANCER THERAPIES

Bethesda, MD, USA, March 4-6, 2010
 
     
 

Accreditation and Credit Designation Statements

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Omnia Education and the NDDO Education Foundation. Omnia Education is accredited by the ACCME to provide continuing medical education for physicians. Omnia Education designates this educational activity for a maximum of 12.75 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ESMO’s E-Learning and Continued Medical Education Working Group has assigned 17 Cat. 1 ESMO-MORA points to TAT 2010. See www.esmo.org for details of ESMO MORA (Medical Oncologist's Recertification Approval).



TAT 2010 homepage

Organization & partners

Committees

Program

CME

Presentations online (n.a.)
MDICT Task Force
Next meeting (n.a.)
Contact